Saturday 17 October 2026
Export UHS’s income statement to Excel — free account
Universal Health Services, Inc.
UHS Healthcare Medical Care Facilities
Universal Health Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $17.4 billion, up 9.71% from fiscal 2024. In the quarter to June 2026, revenue grew 8.27%, EPS grew 9.47%, free cash flow fell 23.8% and total debt rose 5.87%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten.
185.10
2.26
−1.21%
Follow UHS
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
5.99 | 7.36 | 9.29 | 9.58 |
+8 more quarters Free account |
P/S ratio |
0.49 | 0.62 | 0.80 | 0.76 | |
P/FCF ratio |
10.49 | 11.98 | 16.32 | 13.56 | |
P/Operating CF |
20.01 | 27.21 | 24.12 | 33.82 | |
P/B ratio |
1.17 | 1.45 | 1.89 | 1.78 | |
Price to Tangible BV |
2.46 | 3.08 | 4.14 | 3.97 | |
EV/Sales |
0.75 | 0.87 | 1.06 | 1.03 | |
EV/EBITDA |
5.03 | 5.82 | 7.07 | 6.84 | |
EV/Operating CF |
7.55 | 8.14 | 9.91 | 8.96 | |
EV/FCF |
16.07 | 17.00 | 21.76 | 18.38 | |
Quick Ratio |
0.89 | 0.88 | 0.85 | 0.85 | |
Current Ratio |
1.12 | 1.08 | 1.05 | 1.03 | |
Net Debt/EBITDA |
6.89 | 6.97 | 6.78 | 6.77 | |
Debt/Assets |
30.45% | 30.03% | 30.61% | 30.57% | |
Debt/Equity |
0.64 | 0.63 | 0.65 | 0.65 | |
Asset Turnover |
1.17 | 1.16 | 1.16 | 1.14 | |
Operating CF/Net income |
1.24 | 1.15 | 1.29 | 1.02 | |
Capex/Depreciation |
(1.36) | (1.40) | (1.61) | (1.60) | |
Interest Coverage |
12.95 | 13.54 | 12.25 | 13.57 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
46.15% | 46.45% | 45.62% | 46.09% | |
Intangible Assets out of Total Assets |
0.25 | 0.25 | 0.26 | 0.26 | |
Share Based Compensation of Revenue |
0.49% | 0.50% | 0.56% | 0.55% | |
Graham Net Nets |
(0.53) | (0.43) | (0.34) | (0.38) | |
Graham Number |
266.46 | 259.71 | 246.89 | 234.85 | |
Earnings Yield |
16.70% | 13.58% | 10.77% | 10.44% | |
Free Cash Flow Yield |
9.53% | 8.35% | 6.13% | 7.38% | |
Revenue per Share |
77.74 | 73.61 | 70.56 | 71.38 | |
Operating CF per Share |
7.43 | 6.58 | 9.04 | 6.05 | |
Capex per Share |
(3.82) | (3.56) | (4.13) | (3.93) | |
Free Cash Flow per Share |
3.62 | 3.02 | 4.91 | 2.11 | |
Cash per Share |
2.33 | 1.95 | 2.17 | 1.79 | |
Shareholders Equity per Share |
127.09 | 123.32 | 115.42 | 114.82 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
127.09 | 123.32 | 115.42 | 114.82 | |
Free Cash Flow |
215.67 | 184.47 | 312.15 | 133.11 | |
Working Capital |
381.67 | 255.62 | 168.31 | 98.77 | |
Capital Expenditures |
(227.63) | (217.16) | (262.54) | (247.57) | |
Net Current Asset Value |
(4,674.53) | (4,650.34) | (4,780.89) | (4,855.46) | |
EV/EBIT |
6.60 | 7.60 | 9.27 | 8.95 | |
Capex to Sales |
0.05 | 0.05 | 0.06 | 0.06 | |
Price to Operating Income |
4.31 | 5.35 | 6.95 | 6.60 | |
| Other line items | |||||
Average Receivables |
2,551.68 | 2,578.31 | 2,390.09 | 2,399.80 | |
Average Payables |
2,324.41 | 2,224.40 | 1,524.14 | 2,114.33 | |
Average Inventory |
228.44 | 225.70 | 226.53 | 223.36 | |
Average Assets |
15,460.54 | 15,278.29 | 14,998.67 | 14,848.89 | |
Average Common Equity |
7,333.57 | 7,201.76 | 7,044.16 | 6,955.79 |
Columns are period end dates